CellChem Pharmaceuticals Ondansetron Product Recall (2019-10-16)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
A. CCP-Ondansetron 8 mg Tablet;
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 409423 | B. CCP-Ondansetron 4 mg Tablet | - Recalling Firm
- Cellchem Pharmaceuticals Inc
- Unit 1, 30 Concourse Gate,
- Ottawa
- K2E 7V7
- Ontario
- CANADA
- Marketing Authorization Holder
- Cellchem Pharmaceuticals Inc
- Unit 1, 30 Concourse Gate,
- Ottawa
- K2E 7V7
- Ontario
- CANADA
| DIN 0245880 | Tablet | Ondansetron 4 mg |
| 409424 | A. CCP-Ondansetron 8 mg Tablet | - Recalling Firm
- Cellchem Pharmaceuticals Inc
- Unit 1, 30 Concourse Gate,
- Ottawa
- K2E 7V7
- Ontario
- CANADA
- Marketing Authorization Holder
- Cellchem Pharmaceuticals Inc
- Unit 1, 30 Concourse Gate,
- Ottawa
- K2E 7V7
- Ontario
- CANADA
| DIN 02458802 | Tablet | Ondansetron 8 mg |
A. CCP-Ondansetron 8 mg Tablet;
B. CCP-Ondansetron 4 mg Tablet
Affected lot is labelled with the incorrect indication found on the inner label.